Expression and purification of Src-family kinases for solution NMR studies

Methods in Molecular Biology

Volumn 831, Issue , 2012, Pages 111-131

  Piserchio, Andrea ^a   Cowburn, David ^b   Ghose, Ranajeet ^c  

^a CITY COLLEGE OF NEW YORK   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Escherichia coli expression systems; Protein tyrosine kinases; Src family kinases

Indexed keywords

HEAT SHOCK PROTEIN 90; PROTEIN TYROSINE KINASE;

ARTICLE; BIOREACTOR; CHEMICAL STRUCTURE; ENZYME ACTIVE SITE; ESCHERICHIA COLI; GEL CHROMATOGRAPHY; GENE VECTOR; GENETICS; ION EXCHANGE CHROMATOGRAPHY; ISOLATION AND PURIFICATION; ISOTOPE LABELING; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE; POLYACRYLAMIDE GEL ELECTROPHORESIS;

BIOREACTORS; CATALYTIC DOMAIN; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, ION EXCHANGE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; GENETIC VECTORS; HSP90 HEAT-SHOCK PROTEINS; ISOTOPE LABELING; MODELS, MOLECULAR; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; SRC-FAMILY KINASES;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 84855870177     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-480-3_7     Document Type: Article

References (65)

1. Hunter, T. (2000) Signaling - 2000 and beyond. Cell 100 , 113-127. (Pubitemid 30046300)
2. Johnson, L. N. (2009) The regulation of protein phosphorylation. Biochem. Soc. Trans . 37 , 627-641.
3. Tarrant, M. K., and Cole, P. A. (2009) The chemical biology of protein phosphorylation. Annu. Rev. Biochem . 78 , 797-825.
4. Ostman, A., and Bohmer, F. D. (2001) Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases. Trends Cell Biol . 11 , 258-266. (Pubitemid 32441736)
5. Shi, Y. (2009) Serine/threonine phosphatases: mechanism through structure. Cell 139 , 468-484.
6. Kolibaba, K. S., and Druker, B. J. (1997) Protein tyrosine kinases and cancer. Biochim. Biophys. Acta 1333 , F217-248.
7. Blume-Jensen, P., and Hunter, T. (2001) Oncogenic kinase signalling. Nature 411 , 355-365. (Pubitemid 32467045)
8. Chong, P. K., Lee, H., Kong, J. W., Loh, M. C., Wong, C. H., and Lim, Y. P. (2008) Phosphoproteomics, oncogenic signaling and cancer research. Proteomics 8 , 4370-4382.
9. Pawson, T., and Kofl er, M. (2009) Kinome signaling through regulated protein-protein interactions in normal and cancer cells. Curr. Opin. Cell Biol . 21 , 147-153.
10. Johnson, L. N. (2009) Protein kinase inhibitors: contributions from structure to clinical compounds. Q. Rev. Biophys . 42 , 1-40.
11. Noble, M. E., Endicott, J. A., and Johnson, L. N. (2004) Protein kinase inhibitors: insights into drug design from structure. Science 303 , 1800-1805. (Pubitemid 38374863)
12. Nichols, G. L. (2003) Tyrosine kinase inhibitors as cancer therapy. Cancer Invest . 21 , 758-771. (Pubitemid 37377331)
13. Shawver, L. K., Slamon, D., and Ullrich, A. (2002) Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell 1 , 117-123.
14. Nolen, B., Taylor, S., and Ghosh, G. (2004) Regulation of protein kinases; controlling activity through activation segment conformation. Mol. Cell 15 , 661-675. (Pubitemid 39194898)
15. Kornev, A. P., and Taylor, S. S. (2010) Defining the conserved internal architecture of a protein kinase. Biochim. Biophys. Acta 1804 , 440-444.
16. Parsons, S. J., and Parsons, J. T. (2004) Src family kinases, key regulators of signal transduction. Oncogene 23 , 7906-7909. (Pubitemid 39468849)
17. Roux, P. P., and Blenis, J. (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev . 68 , 320-344. (Pubitemid 38756868)
18. Chen, Z., Gibson, T. B., Robinson, F., Silvestro, L., Pearson, G., Xu, B., Wright, A., Vanderbilt, C., and Cobb, M. H. (2001) MAP kinases. Chem. Rev . 101 , 2449-2476. (Pubitemid 35373029)
19. Hubbard, S. R., and Till, J. H. (2000) Protein tyrosine kinase structure and function. Annu. Rev. Biochem . 69 , 373-398.
20. Shi, Z., Resing, K. A., and Ahn, N. G. (2006) Networks for the allosteric control of protein kinases. Curr. Opin. Struct. Biol . 16 , 686-692. (Pubitemid 44827734)
21. Fedorov, O., Muller, S., and Knapp, S. (2010) The (un)targeted cancer kinome. Nature Chem. Biol . 6 , 166-169.
22. Grueneberg, D. A., Degot, S., Pearlberg, J., Li, W., Davies, J. E., Baldwin, A., Endege, W., Doench, J., Sawyer, J., Hu, Y., Boyce, F., Xian, J., Munger, K., and Harlow, E. (2008) Kinase requirements in human cells: I. Comparing kinase requirements across various cell types. Proc. Natl. Acad. Sci. U.S.A . 105 , 16472-16477.
23. Baldwin, A., Li, W., Grace, M., Pearlberg, J., Harlow, E., Munger, K., and Grueneberg, D. A. (2008) Kinase requirements in human cells: II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells. Proc. Natl. Acad. Sci. U.S.A . 105 , 16478-16483.
24. Bommi-Reddy, A., Almeciga, I., Sawyer, J., Geisen, C., Li, W., Harlow, E., Kaelin, W. G., Jr., and Grueneberg, D. A. (2008) Kinase requirements in human cells: III. Altered kinase requirements in VHL?/? cancer cells detected in a pilot synthetic lethal screen. Proc. Natl. Acad. Sci. U.S.A. 105 , 16484-16489.
25. Grueneberg, D. A., Li, W., Davies, J. E., Sawyer, J., Pearlberg, J., and Harlow, E. (2008) Kinase requirements in human cells: IV. Differential kinase requirements in cervical and renal human tumor cell lines. Proc. Natl. Acad. Sci. U.S.A . 105 , 16490-16495.
26. Wiesner, S., Wybenga-Groot, L. E., Warner, N., Lin, H., Pawson, T., Forman-Kay, J. D., and Sicheri, F. (2006) A change in conformational dynamics underlies the activation of Eph receptor tyrosine kinases. EMBO J . 25 , 4686-4696. (Pubitemid 44498140)
27. Vajpai, N., Strauss, A., Fendrich, G., Cowan- Jacob, S. W., Manley, P. W., Grzesiek, S., and Jahnke, W. (2008) Solution conformations and dynamics of Abl kinase-inhibitor complexes determined by NMR substantiate the different binding modes of imatinib/nilotinib and dasatinib. J. Biol. Chem . 283 , 18292-18302.
28. Piserchio, A., Ghose, R., and Cowburn, D. (2009) Optimized bacterial expression and purification of the c-Src catalytic domain for solution NMR studies. J. Biomol. NMR 44 , 87-93.
29. Piserchio, A., Warthaka, M., Devkota, A. K., Kaoud, T. S., Lee, S., Abramczyk, O., Ren, P., Dalby, K. N., and Ghose R. (2011) Solution NMR insights into docking interactions involving inactive ERK2. Biochemistry 50 , 3660-3672.
30. Masterson, L. R., Mascioni, A., Traaseth, N. J., Taylor, S. S., and Veglia, G. (2008) Allosteric cooperativity in protein kinase A. Proc. Natl. Acad. Sci. U.S.A . 105 , 506-511. (Pubitemid 351171738)
31. Masterson, L. R., Cheng, C., Yu, T., Tonelli, M., Kornev, A., Taylor, S. S., and Veglia, G. (2010) Dynamics connect substrate recognition to catalysis in protein kinase A. Nature Chem. Biol . 6 , 821-828.
32. Liu, D., Xu, R., and Cowburn, D. (2009) Segmental isotopic labeling of proteins for nuclear magnetic resonance. Meth. Enzymol . 462 , 151-175.
33. Boggon, T. J., and Eck, M. J. ( 2004 ) Structure and regulation of Src family kinases. Oncogene 23 , 7918-7927. (Pubitemid 39468851)
34. Martin, G. S. (2001) The hunting of the Src. Nature Rev. Mol. Cell Biol . 2 , 467-475.
35. Alvarez, R. H., Kantarjian, H. M., and Cortes, J. E. (2006) The role of Src in solid and hematologic malignancies: development of newgeneration Src inhibitors. Cancer 107 ,1918-1929. (Pubitemid 44582963)
36. Russello, S. V., and Shore, S. K. (2003) Src in human carcinogenesis. Front. Biosci . 8 , s1068-1073.
37. Trevino, J. G., Summy, J. M., and Gallick, G. E. (2006) Src inhibitors as potential therapeutic agents for human cancers. Mini Rev. Med. Chem . 6 , 681-687. (Pubitemid 43881119)
38. Grgurevich, S., Mikhael, A., and McVicar, D. W. (1999) The Csk homologous kinase, Chk, binds tyrosine phosphorylated paxillin in human blastic T cells. Biochem. Biophys. Res. Commun . 256 , 668-675. (Pubitemid 29301165)
39. Zrihan-Licht, S., Deng, B., Yarden, Y., McShan, G., Keydar, I., and Avraham, H. (1998) Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferation. J. Biol. Chem . 273 , 4065-4072. (Pubitemid 28103273)
40. Sicheri, F., Moarefi, I., and Kuriyan, J. (1997) Crystal structure of the Src family tyrosine kinase Hck. Nature 385 , 602-609. (Pubitemid 27087567)
41. Weijland, A., Neubauer, G., Courtneidge, S. A., Mann, M., Wierenga, R. K., and Superti- Furga, G. (1996) The purification and characterization of the catalytic domain of Src expressed in Schizosaccharomyces pombe . Comparison of unphosphorylated and tyrosine phosphorylated species. Eur. J. Biochem . 240 , 756-764. (Pubitemid 26321182)
42. Feder, D., and Bishop, J. M. (1990) Purification and enzymatic characterization of pp60c-src from human platelets. J. Biol. Chem . 265 , 8205-8211.
43. Seeliger, M. A., Young, M., Henderson, M. N., Pellicena, P., King, D. S., Falick, A. M., and Kuriyan, J. (2005) High yield bacterial expression of active c-Abl and c-Src tyrosine kinases. Protein Sci . 14 , 3135-3139. (Pubitemid 41770154)
44. Stover, D. R., Liebetanz, J., and Lydon, N. B. (1994) Cdc2-mediated modulation of pp60csrc activity. J. Biol. Chem . 269 , 26885-26889.
45. Pellecchia, M., Bertini, I., Cowburn, D., Dalvit, C., Giralt, E., Jahnke, W., James, T. L., Homans, S. W., Kessler, H., Luchinat, C., Meyer, B., Oschkinat, H., Peng, J., Schwalbe, H., and Siegal, G. (2008) Perspectives on NMR in drug discovery: a technique comes of age. Nature Rev. Drug Discov . 7 , 738-745.
46. Cole, P. A. (1996) Chaperone-assisted protein expression. Structure 4 , 239-242.
47. Nomine, Y., Ristriani, T., Laurent, C., Lefevre, J. F., Weiss, E., and Trave, G. (2001) Formation of soluble inclusion bodies by HPV E6 oncoprotein fused to maltose-binding protein. Protein Expr. Purif . 23 , 22-32. (Pubitemid 32930976)
48. Kapust, R. B., and Waugh, D. S. (1999) Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci . 8, 1668-1674. (Pubitemid 29379949)
49. Wang, D., Huang, X. Y., and Cole, P. A. (2001) Molecular determinants for Csk-catalyzed tyrosine phosphorylation of the Src tail. Biochemistry 40 , 2004-2010. (Pubitemid 32165669)
50. Ozkirimli, E., and Post, C. B. (2006) Src kinase activation: a switched electrostatic network. Protein Sci . 15 , 1051-1062.
51. Cowan-Jacob, S. W. (2006) Structural biology of protein tyrosine kinases. Cell Mol. Life Sci . 63 , 2608-2625. (Pubitemid 44800715)
52. Welch, W. J., and Feramisco, J. R. (1982) Purification of the major mammalian heat shock proteins. J. Biol. Chem . 257 , 14949-14959.
53. Hahn, J. S. (2009) The Hsp90 chaperone machinery: from structure to drug development. BMB Rep . 42 , 623-630.
54. Zuehlke, A., and Johnson, J. L. (2010) Hsp90 and co-chaperones twist the functions of diverse client proteins. Biopolymers 93 , 211-217.
55. Caplan, A. J., Mandal, A. K., and Theodoraki, M. A. (2007) Molecular chaperones and protein kinase quality control. Trends Cell Biol . 17 , 87-92. (Pubitemid 46199182)
56. Karnitz, L. M., and Felts, S. J. (2007) Cdc37 regulation of the kinome: when to hold 'em and when to fold 'em. Science STKE 2007 , pe22.
57. Whitelaw, M. L., Hutchison, K., and Perdew, G. H. (1991) A 50-kDa cytosolic protein complexed with the 90-kDa heat shock protein (hsp90) is the same protein complexed with pp60v-Src hsp90 in cells transformed by the Rous sarcoma virus. J. Biol. Chem . 266 , 16436-16440. (Pubitemid 21907817)
58. Alexandrov, A., Dutta, K., and Pascal, S. M. (2001) MBP fusion protein with a viral protease cleavage site: one-step cleavage/purification of insoluble proteins. Biotechniques 30 , 1194-1198. (Pubitemid 32523820)
59. Dalgarno, D., Stehle, T., Narula, S., Schelling, P., van Schravendijk, M. R., Adams, S., Andrade, L., Keats, J., Ram, M., Jin, L., Grossman, T., MacNeil, I., Metcalf, C., 3rd, Shakespeare, W., Wang, Y., Keenan, T., Sundaramoorthi, R., Bohacek, R., Weigele, M., and Sawyer, T. (2006) Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds. Chem. Biol. Drug Des . 67 , 46-57. (Pubitemid 43884282)
60. Fiaux, J., Bertelsen, E. B., Horwich, A. L., and Wuthrich, K. (2004) Uniform and residue-specific 15 N-labeling of proteins on a highly deuterated background. J. Biomol. NMR 29 , 289-297. (Pubitemid 38864827)
61. Wu, J., Katrekar, A., Honigberg, L. A., Smith, A. M., Conn, M. T., Tang, J., Jeffery, D., Mortara, K., Sampang, J., Williams, S. R., Buggy, J., and Clark, J. M. (2006) Identification of substrates of human protein-tyrosine phosphatase PTPN22. J. Biol. Chem . 281 , 11002-11010. (Pubitemid 43855523)
62. Burz, D. S., Dutta, K., Cowburn, D., and Shekhtman, A. (2006) In-cell NMR for protein- protein interactions (STINT-NMR). Nature Protoc . 1 , 146-152.
63. Selenko, P., and Wagner, G. (2006) NMR mapping of protein interactions in living cells. Nature Meth . 3 , 80-81. (Pubitemid 43173304)
64. Sakakibara, D., Sasaki, A., Ikeya, T., Hamatsu, J., Hanashima, T., Mishima, M., Yoshimasu, M., Hayashi, N., Mikawa, T., Walchli, M., Smith, B. O., Shirakawa, M., Guntert, P., and Ito, Y. (2009) Protein structure determination in living cells by in-cell NMR spectroscopy. Nature 458 , 102-105.
65. Campos-Olivas, R., Marenchino, M., Scapozza, L. and Gervasio, F. L. (2011) Backbone assignment of the tyrosine kinase Src catalytic domain in complex with imatinib. Biomol. NMR Asgn . 5 , 221-224.